Testing pneumonia patients in the emergency room
Part of Brain & nervous system, Genetic & congenital, Infections, Lungs & breathing clinical trials.
This trial studies a new testing method (HCAP-Pcr) for people with pneumonia caught in the hospital or other healthcare settings. Doctors will use a special lung washing procedure called bronchoalveolar lavage to quickly identify the cause of the infection, which could help guide treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 90 years old
- You have a diagnosis of healthcare-associated pneumonia confirmed by chest X-ray and symptoms like fever or high white blood cell count
- You need extra oxygen, a breathing tube, or have a high severity score
- You have a Rankin score of less than 5 (meaning you are not severely disabled)
- You are not pregnant and have a life expectancy of more than 3 months
- You have not been in the hospital for more than 48 hours before getting pneumonia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a fast, new test for lung infections to the usual slower tests. The goal is to see if getting quick results helps doctors choose the right antibiotic or antiviral sooner, which could help you get better faster while in the hospital.
This study tests new ways to diagnose pneumonia faster and more accurately in older adults who come to the emergency room with breathing problems. The goal is to see if these new tests work better than the current methods.
This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.